Dieter Saur, Zachary Hauseman, James Duncan, and Jennifer Klomp discussed "Effector Signaling" in a plenary session at the AACR Special Conference on RAS Oncogenesis and Therapeutics.
#AACRras26 @saurlab.bsky.social
@theaacr
The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
Dieter Saur, Zachary Hauseman, James Duncan, and Jennifer Klomp discussed "Effector Signaling" in a plenary session at the AACR Special Conference on RAS Oncogenesis and Therapeutics.
#AACRras26 @saurlab.bsky.social
The first full day of the AACR Special Conference on RAS Oncogenesis and Therapeutics begins soon, featuring plenary sessions on RAS biochemistry, structure, and mutations as well as early detection advances. #AACRras26
Sandra Misale discussed "Response and Resistance to RAS Blockade in Solid Tumors and Beyond" in a Rising Star Lecture at the AACR Special Conference on RAS Oncogenesis and Therapeutics. #AACRras26 @sandramisale.bsky.social
Drugging RAS: What a Long, Strange Trip Itβs Been β Channing Der addressed this topic in a keynote address to open the AACR Special Conference on RAS Oncogenesis and Therapeutics.
#AACRras26
The AACR Special Conference on RAS Oncogenesis and Therapeutics opens today in Los Angeles with a keynote address by Channing Der. #AACRras26
The AACR Annual Meeting is the touchstone event for the cancer research community. #AACR25 convened 22,000 attendees from 85 countries to explore and expand the continuum of cancer science and medicine. Learn more in the AACR Annual Impact Report:
buff.ly/PSiw06M
Out now! In the new episode of the Believe in Progress podcast, we talk with Metastatic Breast Cancer Survivor, Katie Rabinowitz, about joining the AACR #Runners4Research team, resilience, advocacy, and living well with cancer. Listen here: buff.ly/EI6dDsG
"We want to offer some reassurance that stopping treatment doesn't necessarily mean that the cancer is going to start regrowing immediately." In the latest Cancer Today: How immunotherapies can continue to control cancer after a patient stops treatment. buff.ly/xv85LZr
Join us Saturday, April 18 in San Diego for the AACR Runners for Research 5K Run/Walk to advance lifesaving cancer research! Learn more and register today:
buff.ly/WbTOiZG
#AACR26 #Runners4Research
From mutant mice to meaningful signals: Read about Nobel laureate Fred Ramsdellβs #AACRIO26 keynote on regulatory T cells and immune tolerance on the #AACRBlog: buff.ly/N6PBOS4 #AACRBlog
Microplastics are more prevalent in prostate cancer tumors than in healthy tissue. Read about this story and more in Cancer Today magazine's Week in Cancer News. buff.ly/W9aq3Vo
Cancer survivors have an increased risk for cardiovascular disease, but a cardiologist can help you stay on top of your heart health. Cancer Today outlines the important role cardiologists can play in survivorship care: buff.ly/20bQZqm @susandent.bsky.social
AACR Members: Voting is currently open through February 28 for the following AACR offices:
βPresident-Elect
βBoard of Directors (5 seats)
βNominating Committee (4 seats)
Read the candidates' vision statements and cast your votes today:
buff.ly/O0x6Rxv
Register by February 27 to get the lowest available rates for the AACR Annual Meeting 2026 (April 17-22; San Diego). Learn more:
buff.ly/rpx0sov
#AACR26
Progression in metastatic breast cancer is usually determined by scans, but a recent study looked into using DNA changes found through a blood test to detect resistance and change treatments. Learn more in the latest issue of Cancer Today: buff.ly/OTnAwTh
Brain Borders and CNS Trafficking:
Graeme F. Woodworth, Jonathan Kipnis, and Michael John Mitchel will address this topic in a plenary session at the AACR Special Conference on Brain Cancer (March 23-25, 2026; Philadelphia). Learn more:
buff.ly/CAwsGw8
#AACRbrain26 @jonykipnis.bsky.social
The AACR will provide childcare services for attendees during the AACR Annual Meeting 2026 (April 17-22; San Diego). Advance registration by March 27 is encouraged. Learn more:
buff.ly/rwXrnw6
#AACR26
Institutions developing and delivering impactful summer research opportunities for high school students can apply for funding through the AACR CARES High School Scholars Program. Apply by February 25. Learn more: buff.ly/IcHFp9W
Institutions developing and delivering impactful summer research opportunities for high school students can apply for funding through the AACR CARES High School Scholars Program. Application deadline: February 25, 2026. Learn more and apply: buff.ly/IcHFp9W
Cancer vaccines are here, and research is identifying how to push T cells even further so they thrive in the tumor microenvironment. Learn more about the openingβnight #AACRIO26 keynote addresses from #AACRFellows Elizabeth Jaffee and Philip Greenberg on the #AACRBlog: buff.ly/uKglwKq
This week in cancer news: FDA approves a tumor treating fields device for pancreatic cancer, chemicals linked to breast cancer and other health concerns found in hair extension products, and more. buff.ly/mhyr0vm
Former AACR President Elizabeth Jaffee, MD, FAACR, highlights how #AACRio26 brings together immunologists and others from across the cancer research community to accelerate progress in immuno-oncology for the benefit of patients everywhere. buff.ly/CpEPTjI #AACRFellows
Small lymphocytic lymphoma isΒ a type of non-Hodgkin lymphoma in which cancer cells are largely in the lymph nodes rather than the blood.
More than 23,500 people living in the United States were diagnosed with chronic lymphocytic leukemia last year. Learn more about treatment options for CLL: buff.ly/wQk6Uj0
Yesterday, the @US_FDA approved the oral Bruton's tyrosine kinase inhibitor acalabrutinib in combination with the BCL-2 inhibitor venetoclax for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Learn more: buff.ly/aN5Td1L
Cutaneous squamous cell carcinoma isn't the most talked-about skin cancer, but it's common and can become metastatic in some cases. Learn what to ask about when confronted by this diagnosis in Cancer Today magazine. buff.ly/b2EOGPZ
Regulation of Immune Response to Cancer: Padmanee Sharma and Patrick Hogan addressed this topic in a major symposium at the AACR IO Conference on Discovery and Innovation in Cancer Immunology. #AACRIO26 @pamsharmamdphd.bsky.social
Renato Ostuni, Robert M. Samstein, and Thornton Thompson discussed "Immune Suppressive Myeloid Cells" in a major symposium at the AACR IO Conference on Discovery and Innovation in Cancer Immunology. #AACRIO26 @ostunilab.bsky.social
AACR Immuno-Oncology Conference cochair Antoni Ribas discusses what makes #AACRio26 unique, what he's excited about in the field, and the impact of immunotherapy on patients with cancer.Β buff.ly/ohArRho
Join us Saturday, April 18 in San Diego for the AACR Runners for Research 5K Run/Walk to advance lifesaving cancer research! Learn more and register today:
buff.ly/WbTOiZG
#AACR26 #Runners4Research